Vasopressor agents; influence of acidosis on cardiac and vascular responsiveness.
D000138:Acidosis / Q000150:complications*; D000818:Animals; D004285:Dogs; D004837:Epinephrine; D006321:Heart; D006801:Humans; D008680:Metaraminol; D009638:Norepinephrine; D012769:Shock / Q000150:complications*; D013566:Sympathomimetics / Q000627:therapeutic use*; D014662:Vasoconstrictor Agents
D013566:Sympathomimetics; D014662:Vasoconstrictor Agents; D008680:Metaraminol; D009638:Norepinephrine; D004837:Epinephrine
ACIDOSIS/complications; SHOCK/complications; SYMPATHOMIMETICS/therapeutic use